China Radiofrequency Ablation Devices Market Size & Outlook
Related Markets
China radiofrequency ablation devices market highlights
- The China radiofrequency ablation devices market generated a revenue of USD 199.4 million in 2023 and is expected to reach USD 473.9 million by 2030.
- The China market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
- In terms of segment, disposable equipment was the largest revenue generating component type in 2023.
- Disposable Equipment is the most lucrative component type segment registering the fastest growth during the forecast period.
Radiofrequency ablation devices market data book summary
| Market revenue in 2023 | USD 199.4 million |
| Market revenue in 2030 | USD 473.9 million |
| Growth rate | 13.2% (CAGR from 2023 to 2030) |
| Largest segment | Disposable equipment |
| Fastest growing segment | Disposable Equipment |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
| Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
Other key industry trends
- In terms of revenue, China accounted for 4.2% of the global radiofrequency ablation devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan radiofrequency ablation devices market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 473.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiofrequency Ablation Devices Market Scope
Radiofrequency Ablation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AngioDynamics Inc | View profile | 815 | 14 Plaza Drive, Latham, NY, United States, 12110 | https://www.angiodynamics.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
China radiofrequency ablation devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.78% in 2023. Horizon Databook has segmented the China radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Many studies in China demonstrate the upcoming need for utilization RFA technology as an alternative to conventional surgical treatments, boosting growth of the market. HCC is the most prevalent form of malignancy in the liver and is the fourth leading cause of cancer-related deaths.
In China, consequently accounting for more than 50% of HCC cases worldwide. Both RFA and hepatic resection are accepted as first-line of treatment for HCC in China. However, the indications for both the treatment options are distinct and do not coincide.
For instance, according to the 2017 guideline for HCC treatment, liver resection is the first-line of treatment for two to three nodules or a single tumor along with the normal liver functioning and no indication for vascular invasion/extrahepatic lesions.
Reasons to subscribe to China radiofrequency ablation devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China radiofrequency ablation devices market databook
-
Our clientele includes a mix of radiofrequency ablation devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China radiofrequency ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into China radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China radiofrequency ablation devices market size, by component type, 2018-2030 (US$M)
China Radiofrequency Ablation Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
